Evidence map›Paper›PMID 32148376›Full record

ReviewWorld journal of gastroenterology2020

Therapies to modulate gut microbiota: Past, present and future.

Akshita Gupta, Srishti Saha, Sahil Khanna

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 79 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Microbiology spectrum · 2025
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism.Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Systematic Design of Adenosine Analogs as Inhibitors of aJournal of medicinal chemistry · 2023
    Article
  17. Article
  18. Review
  19. Metabolites Analysis of Anti-Myocardial Ischemia Active Components ofInternational journal of molecular sciences · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Akshita GuptaDepartment of Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.
Srishti SahaDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, United States.
Sahil KhannaDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, United States. khanna.sahil@mayo.edu.
Assembly Biosciences (United States) · USMayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human gut microbiota comprises of a complex and diverse array of microorganisms, and over the years the interaction between human diseases and the gut microbiota has become a subject of growing interest. Disturbed microbial milieu in the gastrointestinal tract is central to the pathogenesis of several diseases including antibiotic-associated diarrhea and

Indexed as

ForecastingGastrointestinal MicrobiomeFecal Microbiota TransplantationFecesHumansClostridioides difficile infectionFecal microbiota transplantationInflammatory bowel diseaseMicrobial replacement therapiesMicrobiomeMicrobiota

Identifiers

PMID32148376
PMCPMC7052537
OpenAlexW3008183445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.